Patent · US Active

Inhibitors of cyclin-dependent kinases, compositions and uses related thereto

US8097619B2 · kind B2 · utility

0Cited by
8References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 21, 2004
Grant dateJan 17, 2012
Priority date
Expiry dateJan 24, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention pertains to novel cyclin dependent kinase inhibitors (cdks) and specifically, but not exclusively, as inhibitors of cdk/cyclin complexes. As described herein, the inhibitors of this invention are capable of inhibiting the cell-cycle machinery and consequently may be useful in modulating cell-cycle progression, untimately controlling cell growth and differentiation. Such compounds would be useful for treating subjects having disorders associated with excessive cell proliferation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.